BridgeBio Pharma, Inc. (BBIO)

73.17 -4.08 (-5.28%) USD  |  NASDAQ  |  Jan 12, 10:13
More

BridgeBio Pharma Operating Income (TTM)

Operating Income (TTM) Chart

View Operating Income (TTM) for BBIO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Operating Income (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Operating Income (TTM) Range, Past 5 Years

View Operating Income (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Operating Income (TTM) Benchmarks

View Operating Income (TTM) Benchmarks
Start Trial
Pfizer Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade
Supernus Pharmaceuticals, Inc. Upgrade
Ionis Pharmaceuticals, Inc. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade